Methods of assessing renal function

被引:69
作者
Filler, Guido [1 ,2 ,3 ]
Yasin, Abeer [1 ]
Medeiros, Mara [4 ]
机构
[1] Univ Western Ontario, London Hlth Sci Ctr, Childrens Hosp, Dept Pediat, London, ON N6A 5W9, Canada
[2] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON N6A 3K7, Canada
[3] Univ Western Ontario, London Hlth Sci Ctr, Dept Med, London, ON N6A 5W9, Canada
[4] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Nefrol, Mexico City, DF, Mexico
关键词
Inulin; Nuclear medicine; Cystatin C; eGFR; Creatinine; Chronic kidney disease; GLOMERULAR-FILTRATION-RATE; BETA-TRACE-PROTEIN; SERUM CYSTATIN-C; CHRONIC KIDNEY-DISEASE; CREATININE CLEARANCE METHOD; PLASMA-CLEARANCE; REFERENCE INTERVALS; TC-99M-DTPA RENOGRAPHY; ESTIMATING GFR; MARKER;
D O I
10.1007/s00467-013-2426-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Accurate assessment of renal function is critical for appropriate drug dosing of renally excreted compounds. Glomerular filtration rate (GFR) is considered the best marker of kidney function. Inulin clearance forms the gold standard for measuring GFR, both in adults and in children. The method is invasive, cumbersome, and smaller children require urinary catheterization for accurate timed urine collections. Nuclear medicine methods replaced inulin clearance in the 1970s after Cr-51 EDTA clearance was introduced. Inulin has no plasma protein binding, whereas all commonly used radioisotopes have a small amount of plasma protein binding that leads to lower values. Only iohexol does not have significant plasma protein binding. The underestimation due to plasma protein binding is partially offset by overestimation due to the use of non-compartmental pharmacokinetic modeling of the plasma disappearance of the radioisotope. The problem could be overcome with a urinary nuclear medicine clearance method, but these have not been validated in children. Endogenous markers of GFR include serum creatinine and low molecular weight proteins such as cystatin C and beta-trace protein. Of these, estimation of GFR using cystatin C appears to be the most promising, although its accuracy in pregnancy and in the neonatal period may be limited.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 99 条
[31]   Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? [J].
Filler, G ;
Lepage, N .
PEDIATRIC NEPHROLOGY, 2003, 18 (10) :981-985
[32]   Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children [J].
Filler, G ;
Browne, R ;
Seikaly, MG .
PEDIATRIC TRANSPLANTATION, 2003, 7 (01) :18-24
[33]  
Filler G, 2002, CLIN CHEM, V48, P729
[34]   How to Measure Renal Function in Children - What is the Role of Cystatin C? [J].
Filler, Guido .
CURRENT PEDIATRIC REVIEWS, 2006, 2 (03) :225-231
[35]   How to monitor renal function in pediatric solid organ transplant recipients [J].
Filler, Guido ;
Sharma, Ajay P. .
PEDIATRIC TRANSPLANTATION, 2008, 12 (04) :393-401
[36]   The usefulness of cystatin C and related formulae in pediatrics [J].
Filler, Guido ;
Huang, Shih-Han S. ;
Yasin, Abeer .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (12) :2081-2091
[37]   Cystatin C for the assessment of GFR in neonates with congenital renal anomalies [J].
Filler, Guido ;
Grimmer, Joanne ;
Huang, Shih-Han Susan ;
Bariciak, Erika .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (09) :3382-3384
[38]   Are fibroblast growth factor 23 concentrations in renal transplant patients different from non-transplanted chronic kidney disease patients? [J].
Filler, Guido ;
Liu, Daisy ;
Sharma, Ajay Parkash ;
Grimmer, Joanne .
PEDIATRIC TRANSPLANTATION, 2012, 16 (01) :73-77
[39]   Challenges in pediatric transplantation: The impact of chronic kidney disease and cardiovascular risk factors on long-term outcomes and recommended management strategies [J].
Filler, Guido .
PEDIATRIC TRANSPLANTATION, 2011, 15 (01) :25-31
[40]   The challenges of assessing acute kidney injury in infants [J].
Filler, Guido M. .
KIDNEY INTERNATIONAL, 2011, 80 (06) :567-568